The use of primates in screening dependence liability.
D000818:Animals; D002492:Central Nervous System Depressants / Q000494:pharmacology; D003061:Codeine / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D000882:Haplorhini; D006801:Humans; D008251:Macaca / Q000502:physiology*; D008253:Macaca mulatta / Q000502:physiology*; D009021:Morphine Dependence / Q000150:complications / Q000503:physiopathology; D009269:Nalorphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology; D012646:Self Administration; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000517:prevention & control; D019966:Substance-Related Disorders / Q000209:etiology*; D013997:Time Factors
D002492:Central Nervous System Depressants; D009292:Narcotic Antagonists; D009294:Narcotics; D009270:Naloxone; D009269:Nalorphine; D003061:Codeine